Identification of Early and Extra-Early Maturing Tropical Maize Inbred Lines with Multiple Disease Resistance for Enhanced Maize Production and Productivity in Sub-Saharan Africa

Maize, a staple for millions across sub-Saharan Africa (SSA), faces major biotic constraints affecting production and safety of the crop. These include northern corn leaf blight (NCLB), southern corn leaf blight (SCLB), Curvularia leaf spot (CLS), and aflatoxin contamination by Exserohilum turcicum, Bipolaris maydis, Curvularia lunata, and Aspergillus flavus, respectively. Farmers in SSA would benefit tremendously if high-yielding maize hybrids with multiple disease resistance (MDR) were developed and commercialized. In all, 49 early-maturing (EM; 90 to 95 days to physiological maturity) and 55 extra-early-maturing (EEM, 80 to 85 days to physiological maturity) inbred lines developed by the International Institute of Tropical Agriculture were identified as resistant to NCLB in field evaluations in multiple agroecologies of Nigeria in 2017 and 2018. From each maturity group, the 30 most resistant inbreds were selected for evaluation for resistance to SCLB and CLS using a detached-leaf assay. Additionally, the inbreds were screened for resistance to kernel rot and aflatoxin contamination using a kernel screening assay. In all, 7 EM and 6 EEM maize inbreds were found to be highly resistant to the three foliar pathogens while 10 inbreds were resistant to the foliar pathogens and supported significantly less (P = 0.01) aflatoxin accumulation than other inbreds. Inbreds having MDR should be tested extensively in hybrid combinations and commercialized. Large-scale use of maize hybrids with MDR would (i) increase maize production and productivity and (ii) reduce losses caused by aflatoxin contamination. Overall, planting of EM and EEM maize hybrids with MDR would contribute to food security, reduced aflatoxin exposure, and increased incomes of maize farmers in SSA. Copyright © 2022 The Author(s). This is an open access article distributed under the CC BY 4.0 International license.